Acorn Biolabs raised $11 million CAD in Series A funding led by Merz Aesthetics to expand its regenerative medicine services
Amount Raised
C$11 Million
Round Type
Series A
TorontoBiotechnologyHealth CareInvestors
Description
Acorn Biolabs, founded in 2017, has announced approximately $11 million CAD ($8 million USD) in Series A funding to enhance its stem cell preservation services for personalized regenerative medicine. The funding round was led by Merz Aesthetics with support from Telus Global Ventures, MDE Investments, The Leslie Group, Lee Li Holdings, and several undisclosed physicians in the aesthetics, orthopedic, and longevity fields. Acorn plans to use the capital to expand its commercial footprint and develop cosmetic offerings.
Quick answer
Acorn Biolabs raised C$11 Million in a Series A round, dated June 3, 2024. Investors: Lee Li Holdings, The Leslie Group, MDE Investments, Telus Global Ventures and Merz Aesthetics. Acorn Biolabs is based in Toronto, Ontario, Canada.
- How much did Acorn Biolabs raise?
- Acorn Biolabs raised C$11 Million in a Series A round on June 3, 2024.
- Who invested in Acorn Biolabs?
- Lee Li Holdings, The Leslie Group, MDE Investments, Telus Global Ventures and Merz Aesthetics are named as investors in this round.
- What does Acorn Biolabs do?
- Toronto-based biotechnology startup Acorn Biolabs aims to provide clients with access to personalized regenerative medicine through preserving cells for future hair regrowth, skin rejuvenation, injury recovery, and..
- Where is Acorn Biolabs based and how big is it?
- Acorn Biolabs is based in Toronto, Ontario, Canada.
- Who are the decision-makers at Acorn Biolabs?
- Fundz holds 1 contact at Acorn Biolabs. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Acorn Biolabs that raised within 45 days of this round, from Fundz verified event records.
- GRO Biosciences raised $27M on July 18, 2024.
- Novocuff raised $26M (Series A) on July 17, 2024.
- Renalys Pharma raised $38M (Series A) on July 17, 2024.
- Loci Orthopaedics raised $14M (Series A) on July 17, 2024.
- NGM Bio raised $122M (Series A) on July 17, 2024.
- Truvian Health raised $74M (Funding Round) on July 17, 2024.
Who to call at Acorn Biolabs, and when
A new round usually means Acorn Biolabs is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Acorn Biolabs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Acorn Biolabs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Acorn Biolabs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Acorn Biolabs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAcorn Biolabs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.